Related Experiment Video
Updated: May 10, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor
Uzma A Hasan1, Claudia Zannetti, Peggy Parroche
1Infections and Cancer Biology Group, International Agency for Research on Cancer, Lyon 69008, France. uzma.hasan@inserm.fr
Abstract:
Human papillomavirus type 16 (HPV16) and other oncogenic viruses have been reported to deregulate immunity by suppressing the function of the double-stranded DNA innate sensor TLR9. However, the mechanisms leading to these events remain to be elucidated. We show that infection of human epithelial cells with HPV16 promotes the formation of an inhibitory transcriptional complex containing NF-κBp50-p65 and ERα induced by the E7 oncoprotein. The E7-mediated transcriptional complex also recruited the histone demethylase JARID1B and histone deacetylase HDAC1. The entire complex bound to a specific region on the TLR9 promoter, which resulted in decreased methylation and acetylation of histones upstream of the TLR9 transcriptional start site. The involvement of NF-κB and ERα in the TLR9 down-regulation by HPV16 E7 was fully confirmed in cervical tissues from human patients. Importantly, we present evidence that the HPV16-induced TLR9 down-regulation affects the interferon response which negatively regulates viral infection. Our studies highlight a novel HPV16-mediated mechanism that combines epigenetic and transcriptional events to suppress a key innate immune sensor.
Insights
Human papillomavirus type 16 (HPV16) suppresses immunity by targeting the TLR9 sensor. The E7 oncoprotein orchestrates an epigenetic and transcriptional complex to down-regulate TLR9, impacting the interferon response to viral infections.
Area of Science:
- Immunology
- Virology
- Epigenetics
Background:
- Oncogenic viruses like HPV16 can disrupt immune responses by inhibiting innate sensors such as TLR9.
- The precise mechanisms by which HPV16 suppresses TLR9 function remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying HPV16-mediated suppression of the TLR9 innate immune sensor.
- To investigate the role of the HPV16 E7 oncoprotein in this regulatory process.
Main Methods:
- Infection of human epithelial cells with HPV16.
- Analysis of transcriptional complex formation involving NF-κBp50-p65, ERα, JARID1B, and HDAC1.
- Chromatin immunoprecipitation assays to assess binding to the TLR9 promoter.
- Histone methylation and acetylation analysis.
- Validation in human cervical tissues.
Main Results:
- HPV16 E7 oncoprotein induces an inhibitory complex containing NF-κBp50-p65 and ERα.
- This complex recruits JARID1B and HDAC1, binding the TLR9 promoter.
- Epigenetic modifications (decreased histone methylation and acetylation) lead to TLR9 down-regulation.
- NF-κB and ERα involvement confirmed in patient-derived cervical tissues.
- HPV16-induced TLR9 suppression impairs the interferon response.
Conclusions:
- A novel mechanism of HPV16-mediated immune evasion involves epigenetic and transcriptional suppression of TLR9.
- The E7 oncoprotein plays a critical role in orchestrating this suppression.
- Targeting TLR9 impacts the host's interferon-mediated antiviral defense.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Co-activators and Co-repressors
Repressible Operon: trp Operon
Mechanisms of Retrovirus-induced Cancers

